A nurse is caring for a client who has a prescription for ceftriaxone. The nurse should monitor the client for which of the following adverse effects?
Constipation
Maculopapular rash
Pitting edema
Concentrated urine
The Correct Answer is B
B. Maculopapular rash is a potential adverse effect of ceftriaxone. It is a type of skin rash characterized by flat, red areas (macules) and raised, bumpy areas (papules). If a client develops a rash while taking ceftriaxone, it should be reported to the healthcare provider for evaluation.
A. Constipation is not a common adverse effect of ceftriaxone. It is more commonly associated with other medications or medical conditions unrelated to ceftriaxone.
C. Pitting edema is not a common adverse effect of ceftriaxone. It may occur as a result of other medical conditions or medications, but it is not specifically associated with ceftriaxone.
D. Concentrated urine is not a common adverse effect of ceftriaxone.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
D. Chills are a hallmark sign of febrile nonhemolytic reactions. These reactions typically present with fever, chills, and occasionally rigors (shivering). They are caused by recipient antibodies reacting to donor leukocytes or cytokines present in the transfused blood components.
A. Dyspnea (difficulty breathing) is not typically associated with febrile nonhemolytic reactions. It is more commonly seen in acute hemolytic reactions or transfusion-related acute lung injury (TRALI).
B. Urticaria (hives) is more commonly associated with allergic transfusion reactions rather than febrile nonhemolytic reactions.
C. Vomiting is not a characteristic feature of febrile nonhemolytic reactions. It may occur in some cases of transfusion reactions, but it is not specific to febrile nonhemolytic reactions.
Correct Answer is A
Explanation
A. When administering a TST, the nurse should select an injection site that is free of scar tissue and areas with excessive hair, veins, or visible lesions. The preferred site for TST administration is the volar aspect of the forearm, approximately 2-4 inches below the elbow.
B. After administering the TST, the nurse should not massage or manipulate the injection site. Massaging the site can cause irritation or spread the solution, leading to inaccurate results.
C. he TST is administered intradermally, typically with a 27-gauge needle. The needle should be inserted with the bevel facing upward at a 5-15-degree angle.
D. The standard dose of tuberculin solution (e.g., purified protein derivative, PPD) for a TST is 0.1 mL containing 5 tuberculin units (TU).
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today